Androgenetic alopecia and COVID-19: Is there a clinical connection?Article Published on 2022-02-012023-07-07 Journal: Journal of cosmetic dermatology [Category] COVID19(2023년), [키워드] androgenetic alopecia COVID-19 population at risk Risk factors SARS-COV-2 infection Treatment. [DOI] 10.1111/jocd.14670 PMC 바로가기
Platelet-Rich Plasma Treatment for Accelerated Androgenetic Alopecia Pattern Hair Loss After COVID-19 Infection: A Case SeriesArticle Published on 2022-02-012023-07-07 Journal: Journal of cosmetic dermatology [Category] COVID19(2023년), [키워드] androgenetic alopecia COVID-19 Hair loss platelet-rich plasma telogen effluvium. [DOI] 10.1111/jocd.14721 PMC 바로가기
COVID-19 induced telogen effluvium코로나19 유발 휴지기 유출Article Published on 2021-11-012022-09-11 Journal: Dermatologic therapy [Category] SARS, 치료기술, [키워드] absence AGA androgenetic alopecia average Chain Reaction clinician conducted correlation COVID-19 detect determine develop Diagnosis effluvium emotional emotional stress febrile Fever Frequency hair Hair loss Hospitalization hospitalized patient hospitalized patients hypertension incidence medication medications men Outpatient outpatients pandemic Patient polymerase chain polymerase chain reaction post-COVID-19 patient Post-COVID-19 patients presenting proportion respiratory symptom respiratory symptoms responsible reverse transcription reverse transcription polymerase chain reaction RT-PCR SARS-CoV-2 SARS-COV-2 infection severe COVID-19 severity of COVID-19 significantly higher Stress telogen effluvium telogen effluvium. the SARS-CoV-2 Usage women [DOI] 10.1111/dth.15175 PMC 바로가기 [Article Type] Article
Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled TrialMedicine Published on 2021-07-192022-10-31 Journal: Frontiers in Medicine [Category] COVID-19, [키워드] 1:1 95% confidence interval acute respiratory distress Administered adverse events Androgen receptor androgenetic alopecia anti-androgen therapy antiandrogen antiandrogens Brazil conducted COVID-19 demonstrated determine double-blinded effective Follow-up Hospitalization intention-to-treat analysis men Patient patients died Placebo placebo group placebo-controlled clinical trial primary endpoint protective effect proxalutamide Randomized Rate receiving receptor recruited reported risk syndrome TMPRSS2 transmembrane protease serine 2 treated Treatment usual care was reduced with COVID-19 [DOI] 10.3389/fmed.2021.668698 PMC 바로가기 [Article Type] Medicine
Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled TrialInfectious Disease Published on 2021-02-222022-10-31 Journal: Cureus [Category] COVID-19, [키워드] accelerated acute respiratory syndrome affected AGA Androgen receptor androgenetic alopecia anti-androgen therapy average clinical coronavirus COVID-19 Day defined dependent on double-blinded drugs expressed female female subject inhibitor less men Mild moderate Moderate COVID-19 Modification Patient patients treated Placebo positive proxalutamide Randomized receptor recruited reduced regulated Remission reported Result SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 test severe coronavirus disease significantly subject subjects the placebo group time TMPRSS2 transmembrane transmembrane protease serine 2 treated Treatment Type II pneumocyte viral clearance viral spike protein [DOI] 10.7759/cureus.13492 PMC 바로가기 [Article Type] Infectious Disease
Androgenetic alopecia may be associated with weaker COVID-19 T-cell immune response: An insight into a potential COVID-19 vaccine boosterComment Published on 2021-01-012023-07-11 Journal: Med Hypotheses [Category] SARS, [키워드] Androgen receptor androgenetic alopecia COVID-19 Gabrin sign SARS-CoV-2 vaccine. [DOI] 10.1016/j.mehy.2020.110439 PMC 바로가기 [Article Type] Comment
Clock genes may drive seasonal variation in SARS-CoV-2 infectivity: are we due for a second wave of COVID-19 in the fall?Article Published on 2020-01-012023-07-05 Journal: J Biol Regul Homeost Agents [Category] SARS, [키워드] Androgen receptor androgenetic alopecia COVID-19 daylight SARS-CoV-2 sunlight. [DOI] 10.23812/20-359-L-35 PMC 바로가기